97 related articles for article (PubMed ID: 27608133)
21. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract][Full Text] [Related]
22. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry.
Auerbach AD; Allen RG
Cancer Genet Cytogenet; 1991 Jan; 51(1):1-12. PubMed ID: 1984836
[TBL] [Abstract][Full Text] [Related]
23. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
Guervilly JH; Macé-Aimé G; Rosselli F
Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
[TBL] [Abstract][Full Text] [Related]
24. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
25. Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia.
Meyer S; Barber LM; White DJ; Will AM; Birch JM; Kohler JA; Ersfeld K; Blom E; Joenje H; Eden TO; Malcolm Taylor G
Br J Haematol; 2006 May; 133(3):284-92. PubMed ID: 16643430
[TBL] [Abstract][Full Text] [Related]
26. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.
Liu JM; Young NS; Walsh CE; Cottler-Fox M; Carter C; Dunbar C; Barrett AJ; Emmons R
Hum Gene Ther; 1997 Sep; 8(14):1715-30. PubMed ID: 9322874
[TBL] [Abstract][Full Text] [Related]
27. [Progress of research on protein composition and gene therapy of Fanconi anaemia - review].
Li ZY; Zou YF; Deng YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):231-5. PubMed ID: 15157341
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study.
Auerbach AD; Greenbaum J; Pujara K; Batish SD; Bitencourt MA; Kokemohr I; Schneider H; Lobitzc S; Pasquini R; Giampietro PF; Hanenberg H; Levran O;
Hum Mutat; 2003 Feb; 21(2):158-68. PubMed ID: 12552564
[TBL] [Abstract][Full Text] [Related]
29. Exploring inhibitory potential of Curcumin against various cancer targets by in silico virtual screening.
Mahajanakatti AB; Murthy G; Sharma N; Skariyachan S
Interdiscip Sci; 2014 Mar; 6(1):13-24. PubMed ID: 24464700
[TBL] [Abstract][Full Text] [Related]
30. Targeting DNA repair pathways in AML.
D'Andrea AD
Best Pract Res Clin Haematol; 2010 Dec; 23(4):469-73. PubMed ID: 21130409
[TBL] [Abstract][Full Text] [Related]
31. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
Rosenberg PS; Alter BP; Ebell W
Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
[TBL] [Abstract][Full Text] [Related]
32. Fanconi anemia: current management.
Kook H
Hematology; 2005; 10 Suppl 1():108-10. PubMed ID: 16188650
[TBL] [Abstract][Full Text] [Related]
33. MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups.
Li Y; Youssoufian H
J Clin Invest; 1997 Dec; 100(11):2873-80. PubMed ID: 9389754
[TBL] [Abstract][Full Text] [Related]
34. Fanconi anemia and leukemia: tracking the genes.
Auerbach AD
Leukemia; 1992; 6 Suppl 1():1-4. PubMed ID: 1548931
[TBL] [Abstract][Full Text] [Related]
35. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors.
Saeed MEM; Yücer R; Dawood M; Hegazy MF; Drif A; Ooko E; Kadioglu O; Seo EJ; Kamounah FS; Titinchi SJ; Bachmeier B; Efferth T
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409325
[TBL] [Abstract][Full Text] [Related]
36. Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy.
Parsa FG; Nobili S; Karimpour M; Aghdaei HA; Nazemalhosseini-Mojarad E; Mini E
J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330396
[TBL] [Abstract][Full Text] [Related]
37. A murine model to evaluate immunotherapy effectiveness for human Fanconi anemia-mutated acute myeloid leukemia.
Huang T; Leung B; Huang Y; Price L; Gui J; Lau BW
PLoS One; 2024; 19(1):e0292375. PubMed ID: 38289944
[TBL] [Abstract][Full Text] [Related]
38. Proteomic profiling and bioinformatics analysis identify key regulators during the process from fanconi anemia to acute myeloid leukemia.
Hou H; Li D; Gao J; Gao L; Lu Q; Hu Y; Wu S; Chu X; Yao Y; Wan L; Ling J; Pan J; Xu G; Hu S
Am J Transl Res; 2020; 12(4):1415-1427. PubMed ID: 32355551
[TBL] [Abstract][Full Text] [Related]
39. Interaction of curcumin with phosphatidylcholine: A spectrofluorometric study.
Began G; Sudharshan E; Udaya Sankar K; Appu Rao AG
J Agric Food Chem; 1999 Dec; 47(12):4992-7. PubMed ID: 10606563
[TBL] [Abstract][Full Text] [Related]
40. A Multidrug Approach to Modulate the Mitochondrial Metabolism Impairment and Relative Oxidative Stress in Fanconi Anemia Complementation Group A.
Cappelli E; Bertola N; Bruno S; Degan P; Regis S; Corsolini F; Banelli B; Dufour C; Ravera S
Metabolites; 2021 Dec; 12(1):. PubMed ID: 35050128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
